AKT1 and Langerhans cell histiocytosis: In the PI3K-AKT pathway, PIK3CA mutations are present in 17% of BRAF V600E-wildtype ECD and 1.2% of LCH cases, with rare PIK3CD mutations in JXG [6, 27].